Thyroid and Cardiovascular Disease: A Focused Review on the Impact of Hyperthyroidism in Heart Failure

Rafay Khan1, Saad Sikanderkhel1, Junhong Gui1

  • 1Department of Cardiology, University of Tennessee at Chattanooga, 975 E 3rd Street, Chattanooga, TN 37403, USA.

Cardiology Research
|April 8, 2020
PubMed

Insights

Hyperthyroidism can cause heart failure, but the exact link to cardiomyopathy is unclear. More research is needed to understand how thyroid hormones impact heart muscle and function.

Area of Science:

  • Cardiology
  • Endocrinology
  • Internal Medicine

Background:

  • Thyroid hormones significantly influence cardiovascular function.
  • Hypothyroidism is linked to cardiomyopathy, and hyperthyroidism to arrhythmias.
  • The relationship between hyperthyroidism and cardiomyopathy requires further elucidation.

Purpose of the Study:

  • To review the current understanding of heart failure in hyperthyroidism.
  • To explore the mechanisms underlying cardiac dysfunction in hyperthyroid states.
  • To provide physicians with updated knowledge for comprehensive patient care.

Main Methods:

  • Literature search of MEDLINE and PubMed databases.
  • Inclusion of relevant and recent works on hyperthyroidism and cardiovascular system.
  • Development of a consensus for an updated review.

Main Results:

  • Hyperthyroidism's chronic effects on the cardiovascular system are difficult to study due to rarity.
  • Studies show varied effects on ejection fraction and diastolic function in hyperthyroidism.
  • Cardiac dysfunction may stem from vascular changes, arrhythmias, or myocyte remodeling.

Conclusions:

  • The precise mechanisms linking hyperthyroidism to cardiomyopathy are not fully established.
  • Further investigation is crucial to understand cardiac remodeling and fibrosis.
  • Enhanced understanding will improve clinical management of patients with endocrine and cardiovascular conditions.

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
609
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
594
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.1K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
677
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
347